Frozen Embryo Transfer Clinical Trial
Official title:
Cumulus Cell Mitochondrial Activity as a Non-invasive Marker of Embryo Quality
This study aims to test the extent of association of FLIM parameters of cumulus cells with clinical outcomes (clinical pregnancy, ongoing pregnancy at 12 weeks, and live birth) of the embryos that result from the enclosed oocytes.
This study aims to test the extent of association of FLIM parameters of cumulus cells with clinical outcomes (clinical pregnancy, ongoing pregnancy at 12 weeks, and live birth) of the embryos that result from the enclosed oocytes. Participants will be consented to and pre-signed following standard regimens of IVFMD, My Duc Hospital and IVFMD PN, My Duc Phu Nhuan Hospital. The standard is for patients with at least 8 follicles ≥ 10 mm on ultrasonography at the induced ovulation date. Cumulus samples (CCs) will be collected following the protocol on the day of oocyte pick up (OPU), being assigned with the same number as the oocyte from which it was collected, and vitrified with a Cryotech kit until FLIM measurements are performed. Insemination will be performed by using ICSI, 3 - 4 hours after oocyte retrieval. A sample of CCs will be sliced off the cumulus mass of each oocyte judged to be mature based on the cumulus mass disposition (absence of tight corona layers). The remaining cumulus cells will be stripped from the OCCs using hyaluronidase. Only mature oocytes will be inseminated. The fertilization check will be performed under an inverted microscope for a period of 16-18 hours after insemination. On day 3, embryo evaluation will be performed at a fixed time point 66±2 hours after fertilization and, for day 5/6 transfers at 116±2 hours or 140±2 hours, respectively, using the Istanbul consensus. Freeze-all strategy for day 5 embryo will be applied and the first frozen embryo transfer cycle is single embryo transfer. On the other hand, the investigators will stratify embryos into two groups based on the measured FLIM parameters from their associated cumulus cells, corresponding to the "high" 35% and "low" 65% of metabolic scores. The investigators aim for embryos in the "high" metabolic scoring group to have a 10% higher live birth rate than controls. Assuming a current live birth rate of 32%, this corresponds to a hoped-for 42% live birth rate in the "high" group (and a 25% live birth rate in the "low" group). A total of 450 patients are required to detect an effect of this size (power 0.90, two-sided alpha 5%). The primary endpoint of the study will be the live birth rate after the first embryo transfer of the started treatment cycle. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01668446 -
Effect of Adding Sildenafil to Protocol of Endometrial Preparation in Outcome of Frozen-thawed Embryo Transfer Cycles
|
Phase 4 | |
| Terminated |
NCT04092829 -
Impact of Corpus Luteum Presence or Absence in the Incidence of Preeclampsia After Frozen Embryo Transfer
|
N/A | |
| Withdrawn |
NCT04954196 -
Benefit of Amlodipine in HRT Cycle for Frozen Embryo Transfer in the Correction of Uterine Pulsatility Index
|
Phase 2 | |
| Active, not recruiting |
NCT04758871 -
Oral Versus Vaginal Progesterone for Luteal Phase Supplementation in Frozen Embryo Transfer Cycles
|
Phase 4 | |
| Completed |
NCT03740568 -
Effect of Intervention on Progesterone Levels Before Euploid Embryo Transfer in Pregnancy Outcomes.
|
N/A | |
| Completed |
NCT04013438 -
Luteal Phase Support During Frozen Embryo Transfer Cycle
|
Phase 3 | |
| Recruiting |
NCT04371783 -
A Randomized Trial Comparing the Live Birth Rate of Immediate Versus Delayed FET Following a Freeze-all Strategy
|
N/A | |
| Recruiting |
NCT03976544 -
Natural Cycle Versus Hormone Replacement Therapy Cycle for a Frozen-thawed Embryo Transfer in PGT Patients
|
Phase 4 | |
| Recruiting |
NCT04804020 -
Natural Cycle vs. Modified Natural Cycle vs. Artificial Cycle Protocol for Endometrial Preparation.
|
N/A | |
| Completed |
NCT04837768 -
Effect of Intramuscular Progesterone Supplementation on Clinical and Ongoing Pregnancy Rates in Patients With Low Serum Progesterone Levels on the Day of Embryo Transfer in Artificial Frozen Cycles
|
N/A | |
| Terminated |
NCT05802303 -
Estrogen (Gel)Transdermal vs Oral Estrogen for Endometrial Preparation
|
N/A | |
| Recruiting |
NCT05716139 -
Natural Cycle vs Programmed Cycle Frozen Embryo Transfer
|
N/A | |
| Enrolling by invitation |
NCT04455191 -
Comparison of Thawing Embryos in Advance and on the Day of Transfer on Pregnancy Outcomes in FET Cycle
|
N/A | |
| Completed |
NCT03660007 -
Incidence of Pulmonary and Venous Thromboembolism in IVF Pregnancies After Fresh and Frozen Embryo Transfer
|
||
| Not yet recruiting |
NCT04247204 -
Assessment of Endometrial and Sub-endometrial Vascularity Before and After PRP Infusion in Frozen Embryo Transfer Cycles
|
N/A | |
| Recruiting |
NCT06307184 -
Assessing the Convenience of Natural Proliferative Phase Frozen Embryo Transfer
|
||
| Recruiting |
NCT05739019 -
The Impact of Past Coronavirus Disease 19 (COVID-19) Infection on the Live Birth Rates of Frozen Embryo Transfer Cycles
|
||
| Recruiting |
NCT06239376 -
Artificial Cycle With or Without GnRH Agonist Pre-treatment for Frozen Embryo Transfer in Adenomyosis Patients
|
N/A | |
| Completed |
NCT01943812 -
Substituted Frozen Embryo Transfer Cycles With GnRH-agonist Supplementation
|
Phase 4 | |
| Active, not recruiting |
NCT05555121 -
Rescue Progesterone Supplementation During Frozen Embryo Transfer
|
Phase 2 |